Reneuron Share Chat (RENE)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Reneuron Group	LSE:RENE	London	Ordinary Share	GB00B0DZML60	ORD 1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	+0.00p	+0.00%	1.95p	1.90p	2.00p	1.95p	1.95p	1.95p	1,706,384	07:45:41

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	0.0	-18.2	-0.5	-	61.61

Reneuron Share Discussion Threads

Showing 5451 to 5473 of 5475 messages

Chat Pages: 219 218 217 216 215 214 213 212 211 210 209 208 Older

Date	Subject	Author	Discuss
08/8/2017 14:46	Long way to go yet for me to get my money back...	stewart_25	Read Full Thread Reply
08/8/2017 09:37	The strength here continues. It doesn't matter that products and profit might be some way off (pace Amazon, Facebook, etc etc etc) with this kind of co the valuation is all about the potential and, as Woodford notes, there is a great deal in this technology.	small crow	Read Full Thread Reply
07/8/2017 15:55	Anyone going to the AGM next Month? 06/09/17 London. Freddie? Anyone?	algernon2	Read Full Thread Reply
07/8/2017 09:55	I agree with Woodford on the potential for Reneuron but the rationale makes no sense. These guys are burning cash at ~£13m per year and their therapeutic candidates are nowhere near the clinic. So the market is discounting this. The fact that they have £54m cash just means they've got ~ 4 years, at this rate of cash burn, to progress the technology. That said, if this thing was listed in the US, I expect it would be worth 10 x the current market cap, given how exciting and world-leading the technology is and how US investors tend to have more risk appetite for innovation. One for the very long-term. 2p very attractive levels!	rrb	Read Full Thread Reply
07/8/2017 09:45	Ze Germans always state the bleeding obvious! Now they're trying to steal our shares.	alphapig	Read Full Thread Reply
07/8/2017 09:22	"mkt cap equals cash on balance sheet" - That's as at today. Henceforth for the immediate future money is going out and none coming in! - So as always you pays your money and takes your chance!	deutsch3	Read Full Thread Reply
07/8/2017 08:29	Good write up by Woodford mkt cap equals cash on balance sheet	nw99	Read Full Thread Reply
07/8/2017 08:22	Someone likes	richtea2517	Read Full Thread Reply
07/8/2017 07:37	Time to buy?	rayrac	Read Full Thread Reply
06/8/2017 13:17	I seem to remember the cash was raised in a big share issue and is needed to progress the drugs through development and trials, so its a diminishing cash pile rather than something built up from commercial revenues. No position here at present.	deccer1	Read Full Thread Reply
06/8/2017 11:19	Spot on nw	fredd1eboy	Read Full Thread Reply
06/8/2017 08:53	Interesting cash on Bal sheet = mkt cap could be a big winner	nw99	Read Full Thread Reply
04/8/2017 16:21	Massive volume spike	bean02	Read Full Thread Reply
04/8/2017 15:29	About time ...	small crow	Read Full Thread Reply
04/8/2017 14:39	Extract from today's report. My sentiments exactly. https://www.investegate.co.uk/wood-pat-captst-plc/rns/half-year-report/201708040700040863N/ By way of example, ReNeuron, a leading clinical stage stem cell business, had a market capitalisation at period end of £54m. At its latest financial year end (31 March 2017), the company held £53m in cash on its balance sheet, meaning that the stock market is effectively ascribing a value of £1m to the future value of this company's world-class technology. This appears ludicrous, in my view, but it also serves as an effective demonstration of how market inefficiencies can lead to compelling long-term investment opportunities.	127tolmers	Read Full Thread Reply
02/8/2017 12:05	I really feel for you guys as a past holder who saw enough to be disillusioned and sold out. Please do not say that rocket fuel or myself for that matter did not raise a red flag over the moral fibre of the controlling people behind this company; The price is discounting the cash by liabilities when a premium is deserved if they have not lied to you	norbus	Read Full Thread Reply
02/8/2017 10:00	Its a disgrace. Poor Reneuron management has allowed the share price to drop to this ridiculous level. Olav Hellebo with is over inflated salary should be sacked, unless he leads a recovery. At this sp, when we do go for a cash call, we will be ravaged. Get your act together Olav and earn your salary.	fredd1eboy	Read Full Thread Reply
02/8/2017 09:25	Over 3 billion shares in issue and it drops on that?	alphapig	Read Full Thread Reply
31/7/2017 11:11	Interesting yes, but old. Does not contain early Ph2 results which improve conclusions. See recent Proactiv presentations.	127tolmers	Read Full Thread Reply
29/7/2017 16:50	Interesting article https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5510676/	fredd1eboy	Read Full Thread Reply
29/7/2017 16:49	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC551067e6/	fredd1eboy	Read Full Thread Reply
27/7/2017 08:14	Related news: https://www.theguardian.com/science/2017/jul/26/stem-cell-brain-implants-could-slow-ageing-and-extend-life-study-shows	small crow	Read Full Thread Reply
26/7/2017 14:03	No placing; Shake up the register and wake up the dead.	norbus	Read Full Thread Reply

Chat Pages: 219 218 217 216 215 214 213 212 211 210 209 208 Older